Publication | Closed Access
PEBA Regimen (Cisplatin, Etoposide, Bleomycin, and Adriamycin) in the Treatment of Drug-Resistant Choriocarcinoma
27
Citations
0
References
1995
Year
OncologyHealth SciencesMedicinePeba RegimenDrug-resistant ChoriocarcinomaPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug Resistance
No additional data available for this publication yet. Check back later!